Stribild 200 mg

STRIBILD 200 MG tablets are a combination medication used in the treatment of HIV. This oral medication is manufactured by Gilead Sciences Canada Inc. and contains emtricitabine as its active ingredient.

STRIBILD 200 MG tablets are primarily used as part of antiretroviral therapy to manage HIV infection. This medication works by reducing the amount of HIV in the body, helping to control the progression of the disease. It is often prescribed in combination with other HIV medications to achieve optimal results. The specific uses of STRIBILD 200 MG should be discussed with a healthcare provider.

Common effects of STRIBILD 200 MG tablets may include headaches, nausea, and dizziness. Some individuals might experience changes in body fat distribution or rash. These effects can vary from person to person, and not everyone will experience them. It is important to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

STRIBILD 200 MG tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. This medication should not be shared with others, even if they have similar symptoms. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

STRIBILD 200 MG tablets may interact with other medications, including certain antacids, antiviral drugs, and supplements. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect the efficacy of the medication.